Ignite Creation Date:
2025-12-24 @ 10:48 PM
Ignite Modification Date:
2025-12-25 @ 8:18 PM
Study NCT ID:
NCT03490669
Status:
COMPLETED
Last Update Posted:
2024-04-05
First Post:
2018-02-07
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-05-21
Start Date Type:
ACTUAL
Primary Completion Date:
2019-09-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-09-23
Completion Date Type:
ACTUAL
First Submit Date:
2018-02-07
First Submit QC Date:
None
Study First Post Date:
2018-04-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-04
Last Update Post Date:
2024-04-05
Last Update Post Date Type:
ACTUAL